Page 93 - Ageing and Dementia: A compendium of New Zealand research literature
Basic HTML Version
DEMENTIA RESEARCH 76
Guk-Hee, S., Wimo, A., Gauthier, S., O'Connor, D., Ikeda, M., Homma, A., et al. (2009). International price
comparisons of Alzheimer's drugs: a way to close the affordability gap.
International
Psychogeriatrics, 21
(6), 1116-1126
Holden, J., Jayathissa, S., & Young, G. (2008). Delirium among elderly general medical patients in a New
Zealand hospital.
Internal Medicine Journal, 38
(8), 629-634.
Hosford, I., Glass, J., & Baker, N. ( 2003). Relapsing polychondritis- an unusual but potentially treatable
cause of cognitive impairment.
New Zealand Medical Journal, 116
(1175), 76-79.
Jackson, G., Gerard, C., Minko, N., & Parsotam, N. (2014). Variation in benzodiazepine and antipsychotic
use in people aged 65 years and over in New Zealand.
The New Zealand Medical Journal,
127
(1396), 67-78.
Maclean, L. E., Collins. C., & Byrne E. J. (2001). Dementia with Lewy bodies treated with rivastigmine:
effects on cognition, neuropsychiatric symptoms and sleep.
International Psychogeriatrics
,
13
(3),
277-288.
Moffatt, A., & Ticehurst, S. (2013). Mirtazapine-induced massive dyslipidaemia in an elderly woman.
Australian and New Zealand Journal of Psychiatry, 47
(6), 587-588.
